Gene Bio Tech진바이오텍
086060 · KOSDAQ · ₩086060 · 진바이오텍
- Market cap
- ₩44B
- Enterprise value
- ₩34B
- P/E
- 11.9×
- P/B
- 0.8×
- Dividend yield
- 1.0%
- ROE
- 6.5%
- Net margin
- 4.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−15.2% from the high
₩3,525Today: ₩5,080 – ₩5,160₩5,990
Returns
- 1W+2.3%
- 1M+6.6%
- 3M+0.4%
- 6M+6.3%
- YTD+26.7%
- 1Y+28.0%
- Volume today
- 11,720
- 0.7× the 20-day average
- Traded today
- ₩60M
- Listed shares
- 8,610,587
- EPS (12 months)
- ₩426
- Earnings yield 8.4%
Upcoming dates
- Oct 29Dividend Ex-dividend day · ₩30 per share
- Oct 30Dividend Record date · ₩30 per share
- Nov 16Earnings Expected · 3Q results
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 42 of 100 (50 is a normal day for this stock).
- SentimentMixedNews: Only a routine filing about a large shareholder's stake; no clear positive or negative tone. Community: 0 bullish, 0 bearish posts this week.
- MomentumStrong6.3% over the last month; the price is above its 20-day average.
- News impactLow3 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Gene Bio Tech stock overview
Gene Bio Tech (진바이오텍, KRX: 086060) is listed on KOSDAQ, in the Retail & Trade sector. The company operates in two segments: functional feed additives, sold under the Jinbiotech brand, and animal medicines, sold through Dawon Chemical. Its shares closed at ₩5,080 on Oct 27, 2026, down 0.78% on the day, giving it a market value of ₩44B.
Key facts
- Market cap
- ₩44B
- Sector
- Retail & Trade
- Latest price change
- −0.78%
- As of
- Oct 27, 2026
- Main business
- The company operates in two segments: functional feed additives, sold under the Jinbiotech brand, and animal medicines, sold through Dawon Chemical.
Quick answers about Gene Bio Tech
- What does Gene Bio Tech do?
- The company operates in two segments: functional feed additives, sold under the Jinbiotech brand, and animal medicines, sold through Dawon Chemical. Its products, including specialty plant-based peptides, compound enzymes, probiotics and vitamin and mineral premixes, are used in animal feed to support health, growth efficiency and environmental control for livestock and pet food producers in Korea and export markets.
- What is the market cap of Gene Bio Tech?
- The market capitalisation of Gene Bio Tech was ₩44B at the close on Oct 27, 2026.
- Who are the largest shareholders of Gene Bio Tech?
- According to the latest official filings, the largest reported holders are Kim Sung-ho (19.40%, as of Aug 10, 2026); Dental OK (5.01%, as of Oct 27, 2026).
- When is the next earnings report from Gene Bio Tech?
- Korean companies rarely announce results dates in advance. Based on when Gene Bio Tech filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company operates in two segments: functional feed additives, sold under the Jinbiotech brand, and animal medicines, sold through Dawon Chemical. Its products, including specialty plant-based peptides, compound enzymes, probiotics and vitamin and mineral premixes, are used in animal feed to support health, growth efficiency and environmental control for livestock and pet food producers in Korea and export markets.
Written by AI from the company's latest annual report.
- Korean name
- 진바이오텍
- Sector
- Retail & Trade
- Themes
- —
- CEO
- 이찬호
- Founded
- Mar 2000
- Listed
- Apr 2006
- Listed shares
- 8,610,587
- Fiscal year ends
- Month 12
- Website
- www.genebiotech.co.kr
Similar companies
- Samsung C&T028260 · ₩49T₩301,000+3.08%
- POSCO International047050 · ₩8.8T₩49,850+0.61%
- ISC095340 · ₩3.2T₩151,300+7.61%
- Youngone111770 · ₩3T₩68,100+1.04%
- Dong SUH Companies026960 · ₩2.7T₩27,500+0.73%
- Shinsegae004170 · ₩2.3T₩245,0000.00%
- SK Gas018670 · ₩2.3T₩249,000−0.80%
- Lotte Shopping023530 · ₩2.3T₩81,300−0.12%
Recent filings
See all- 중간(분기)배당락Oct 28, 2026
- 5%+ holding reportOct 27, 2026
- Amended: Cash dividend decisionOct 14, 2026
- Cash dividend decisionOct 14, 2026
- Decision on Shareholder Register Closure (Record Date) for Interim (Quarterly) DividendOct 14, 2026
Titles in Korean until English translations are added.
Also known as: Gene Bio Tech / 진바이오텍 / 086060 / KRX:086060
Source: KRX statistical information